Select Committee · Public Accounts Committee
Price increases for generic medications inquiry
Status: Closed
Opened: 14 Jun 2018
Closed: 14 Jun 2018
1 report
Generic medications are medications that can be manufactured by any company. These differ from branded medicines, which are protected by patents for a minimum of 20 years. During 2017, costs of generic medicines rose unexpectedly, putting financial pressure on pharmacies. A recent investigation by the National Audit Office found that the NHS spent £4.3 billion …
Reports
| Title | HC No. | Published | Items | Response |
|---|---|---|---|---|
| 62nd Report - Price increases for generic medications | HC 1184 | 12 Oct 2018 | 0 | — |
Oral evidence sessions
| Date | Witnesses | |
|---|---|---|
| 4 Jul 2018 | Session | View ↗ |
Correspondence
| Date | Direction | Title |
|---|---|---|
| 6 Mar 2019 | To cttee | Letter from Sir Chris Wormald, Department for Health and Social Care, to Meg Hi… |
| 14 Feb 2019 | To cttee | Letter from Chair to Sir Chris Wormald regarding Treasury minute response to Ge… |